MRNA Jun 2024 105.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:14PM EDT. Market open.
| Previous close | 43.02 |
| Open | 43.01 |
| Bid | 42.50 |
| Ask | 50.35 |
| Strike | 105.00 |
| Expiry date | 2024-06-07 |
| Day's range | 43.01 - 43.04 |
| Contract range | N/A |
| Volume | |
| Open interest | 34 |
Investor's Business DailyModerna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
Moderna said Monday its Covid/flu vaccine topped rivals from GSK and Sanofi, and its own Spikevax shot. But Moderna stock fell.
ZacksModerna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Moderna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19 variant JN.1 to the FDA for the upcoming vaccination season.
- Investing.com
Midday movers: Southwest Airlines, CrowdStrike, KKR rise; AMD falls
(Updated - June 10, 2024 11:28 AM EDT)
© 2024 Yahoo. All rights reserved.